Related Experiment Video
Updated: Aug 23, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG
Chiara Brignole1, Fabio Pastorino, Danilo Marimpietri
1Laboratory of Oncology, Gaslini Children's Hospital, Genoa, Italy.
Background:
Expression of the c-myb proto-oncogene in neuroblastoma, the most common extracranial solid tumor of infancy, is linked with cell proliferation and differentiation. Neuroblastoma can be selectively targeted via monoclonal antibodies against the disialoganglioside (GD2) tumor-associated antigen. Liposomes coated with anti-GD2 antibodies (targeted liposomes) and entrapping a c-myb antisense oligonucleotide have antitumor activity. Because antisense oligonucleotides containing CpG motifs can stimulate immune responses, we evaluated the effect of CpG-containing c-myb antisense oligonucleotides encapsulated within targeted liposomes.
Methods:
Antisense (myb-as) and scrambled (myb-scr) control oligonucleotides with CpG motifs were encapsulated within GD2-targeted and non-targeted liposomes. Two murine (nude and SCID-bg) xenograft models of neuroblastoma were established. Mice (groups of 10) were injected intravenously with various oligonucleotide and liposome formulations, and life span, long-term survival, immune cell activation, and cytokine release were measured over time.
Results:
Tumor-bearing mice injected with targeted liposome-CpG-myb-as or targeted liposome-CpG-myb-scr lived longer than mice in any other group, although long-term survival (i.e., more than 120 days) was obtained only in mice injected with targeted liposome-CpG-myb-as. Splenocytes isolated from mice injected with targeted liposome-CpG-myb-as contained activated macrophages, B cells, and natural killer (NK) cells, but only activated NK cells were associated with antitumor cytotoxic activity. In vivo immune cell activation was accompanied by the time-dependent increases in plasma levels of the cytokines interleukin 12 (IL-12; maximum level reached by 2 hours) and interferon gamma (IFN-gamma; maximum level reached by 18 hours) and was dependent on the oligonucleotide CpG motif. Ablation of macrophages or NK cells resulted in a loss of in vivo antitumor activity.
Conclusion:
Immune cell activation, involving the time-dependent activation of macrophages and NK cells, contributes to the antitumor activity of targeted liposome-CpG-myb-as against neuroblastoma and could improve the effectiveness of antitumor targeted liposomes.
Insights
Targeted liposomes with CpG-containing c-myb antisense oligonucleotides significantly improved survival in neuroblastoma models by activating immune cells like macrophages and NK cells.
Area of Science:
- Immunology
- Oncology
- Nanotechnology
Background:
- Neuroblastoma, a common infant cancer, involves c-myb proto-oncogene expression.
- Disialoganglioside (GD2) is a tumor-associated antigen targeted by monoclonal antibodies.
- Liposomes with anti-GD2 antibodies and c-myb antisense oligonucleotides show antitumor effects; CpG motifs can enhance immune responses.
Purpose of the Study:
- To evaluate the antitumor efficacy of CpG-containing c-myb antisense oligonucleotides encapsulated within GD2-targeted liposomes.
- To investigate the role of immune cell activation and cytokine release in the therapeutic response.
Main Methods:
- Encapsulation of antisense (myb-as) and control (myb-scr) oligonucleotides with CpG motifs into targeted and non-targeted liposomes.
- Establishment of murine neuroblastoma xenograft models (nude and SCID-bg).
- Intravenous administration of liposome formulations and assessment of survival, immune cell activation, and cytokine profiles.
Main Results:
- Targeted liposomes with CpG-myb-as significantly increased survival compared to other groups.
- Immune cell activation (macrophages, B cells, NK cells) and increased IL-12 and IFN-gamma levels were observed, dependent on CpG motifs.
- Antitumor activity was dependent on macrophages and NK cells; only NK cells showed direct cytotoxic activity.
Conclusions:
- The combination of targeted liposomes and CpG-myb-as induces immune cell activation, contributing to antitumor activity against neuroblastoma.
- Immune mechanisms, particularly macrophage and NK cell activation, are crucial for the observed therapeutic benefits.
- This approach holds potential for enhancing the effectiveness of targeted liposome-based cancer therapies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Abnormal Proliferation

